home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Merrimack Pharmaceuticals, Inc. - Common Stock (NQ:MACK)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merrimack Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 Next >

Meta Platforms, Hilton Grand Vacations, D.R. Horton, And Some Other Big Stocks Moving Higher On Wednesday ↗

November 09, 2022

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Upstart (UPST) Stock Sinks on Gloomy Forecast ↗

November 09, 2022

Upstart (UPST) stock is sliding lower on Wednesday following a poor performance in the third quarter of 2022 and a weak outlook.

Via InvestorPlace

Why Is Merrimack Pharmaceuticals (MACK) Stock Up 220% Today? ↗

November 09, 2022

Merrimack Pharmaceuticals (MACK) stock is rocketing higher on Wednesday following positive Phase III clinical trial data.

Via InvestorPlace

US Stocks Open Lower; Dow Drops 250 Points ↗

November 09, 2022

U.S. stocks traded lower this morning as investors focused on the outcome of the midterm elections, with the Dow Jones dropping around 250 points on Wednesday.

Via Benzinga

Why Merrimack Shares Are Surging Over 200% Today? ↗

November 09, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 09, 2022

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 09, 2022

Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings...

Via Benzinga

Merrimack Reports Third Quarter 2022 Financial Results

November 03, 2022

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 05, 2022

Wednesday saw 127 companies set new 52-week lows.

Via Benzinga

Merrimack Reports Second Quarter 2022 Financial Results

August 04, 2022

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 03, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 03, 2022

Via Benzinga

Merrimack Pharma-Ipsen's Cancer Drug Fails In Overall Survival Measure ↗

August 03, 2022

Via Benzinga

Merrimack Provides Ipsen Report of Results From Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer

August 03, 2022

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Merrimack Reports First Quarter 2022 Financial Results

May 05, 2022

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

53 Biggest Movers From Yesterday ↗

April 08, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

April 07, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price...

Via Benzinga

50 Biggest Movers From Friday ↗

February 07, 2022

Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 04, 2022

Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is...

Via Benzinga

41 Biggest Movers From Yesterday ↗

January 27, 2022

Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave...

Via Benzinga

32 Stocks Moving In Wednesday's Mid-Day Session ↗

January 26, 2022

Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 32% to $0.7262 after the company announced a share buyback of up to 100 million shares of common stock at $1 per share...

Via Benzinga

3 Penny Stocks Insiders Are Buying ↗

January 14, 2022

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

Merrimack Reports Third Quarter 2021 Financial Results

November 04, 2021

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 27, 2021

Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. Keros Therapeutics's stock is trading at a volume...

Via Benzinga

Merrimack Reports Second Quarter 2021 Financial Results

August 05, 2021

From Merrimack Pharmaceuticals, Inc.

Via Business Wire

Elevation Oncology Files for $100M IPO ↗

June 07, 2021

Elevation Oncology has filed to raise $100 million in an IPO. See SEC prospectus here. Proceeds will be used to support the development of seribantumab that failed...

Via Benzinga

Topics Initial Public Offering Regulatory Compliance

Last Week's Notable Insider Buys Included Evergy, StoneMor, Tattooed Chef And More ↗

April 18, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Even with a new earnings season underway, insiders were...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com